Clinigen Group plc announced earnings guidance for the second half of 2020. Trading to date in the second half of the current financial year has been in line with the Board's expectations. The Group remains in a good position to drive further growth across all parts of the business in the year ahead. The Board believes the Group is well placed to capitalise on the substantial opportunity in its markets. The group's future organic gross profit is targeted to grow by at least 5% to 10%, with fiscal year 2020 set to be at the upper end of this guidance.